Multi-omics characterization of PRMT5-associated MYC and proliferative programs in Group 3 medulloblastoma

Background: Group 3 medulloblastoma (G3-MB) carries the worst prognosis, and validated therapeutic targets downstream of MYC remain limited. We investigated PRMT5-associated molecular and clinical features in G3-MB. Methods and Results: We integrated 763 bulk transcriptomes, approximately 25,000 single-nucleus RNA-seq profiles from 12 G3-MB patients, and 144 paired methylation-expression data. PRMT5 was higher in G3-MB than in SHH tumors and was independently associated with poor overall survival in an institutional validation cohort. Its expression was not associated with copy-number gain, but correlated with promoter hypomethylation and MYC/E2F1/SP1 co-expression. Network analysis placed PRMT5 in a MYC-correlated module enriched for ribosome biogenesis. At single-nucleus resolution, PRMT5-positive tumor cells showed elevated MYC and proliferation programs, although these associations were sensitive to detection threshold and library size. PRMT5-high tumors showed expression of genes linked to PRMT5-inhibitor pathways, DNA damage response, and replication stress. An exploratory seven-gene PRMT5-associated continuous score showed prognostic signal in the training and institutional validation cohorts. Conclusions: Integrated analyses associate PRMT5 with MYC-linked ribosome biogenesis and proliferative programs in G3-MB. PRMT5 is a candidate prognostic marker, and the PRMT5-MYC-ribosome association is a testable preclinical hypothesis; functional studies are needed to establish therapeutic relevance.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11632170/v1
Primary Topic
Glioma Diagnosis and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Multi-omics characterization of PRMT5-associated MYC and proliferative programs in Group 3 medulloblastoma

王子卫, Kaiwen Deng, Zhiyang Chen, Zhaoyang Feng et al.
Research Square
Glioma Diagnosis and Treatment
preprint

Multi-omics characterization of PRMT5-associated MYC and proliferative programs in Group 3 medulloblastoma

王子卫, Kaiwen Deng, Zhiyang Chen, Zhaoyang Feng, Liu Yu, Hailong Liu, Yuyan Liang, Dongyang Wang, Fei Liu, Yu Su, Junyuan Tian, Xuan Chen, Wei Wang, Xi Cheng, Tao Jiang, Qiao Yang, Xiangceng Liu
preprint en

Abstract

Background: Group 3 medulloblastoma (G3-MB) carries the worst prognosis, and validated therapeutic targets downstream of MYC remain limited. We investigated PRMT5-associated molecular and clinical features in G3-MB. Methods and Results: We integrated 763 bulk transcriptomes, approximately 25,000 single-nucleus RNA-seq profiles from 12 G3-MB patients, and 144 paired methylation-expression data. PRMT5 was higher in G3-MB than in SHH tumors and was independently associated with poor overall survival in an institutional validation cohort. Its expression was not associated with copy-number gain, but correlated with promoter hypomethylation and MYC/E2F1/SP1 co-expression. Network analysis placed PRMT5 in a MYC-correlated module enriched for ribosome biogenesis. At single-nucleus resolution, PRMT5-positive tumor cells showed elevated MYC and proliferation programs, although these associations were sensitive to detection threshold and library size. PRMT5-high tumors showed expression of genes linked to PRMT5-inhibitor pathways, DNA damage response, and replication stress. An exploratory seven-gene PRMT5-associated continuous score showed prognostic signal in the training and institutional validation cohorts. Conclusions: Integrated analyses associate PRMT5 with MYC-linked ribosome biogenesis and proliferative programs in G3-MB. PRMT5 is a candidate prognostic marker, and the PRMT5-MYC-ribosome association is a testable preclinical hypothesis; functional studies are needed to establish therapeutic relevance.

Research Square
University of Electronic Science and Technology of China (CN), Capital Medical University (CN), Beijing Tian Tan Hospital (CN), Beijing Children’s Hospital (CN), Beijing YouAn Hospital (CN), University of Chinese Academy of Sciences (CN), BGI Research, Wuhan (CN)
National Natural Science Foundation of China
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon